APPLICATIONS PUBLISHED 27 JULY 2005

Pharmaceutical identification
Euro-Celtique 1555996*

Polymeric assisted benefit agent delivery systems
Procter & Gamble 1555997*

Pharmaceutical formulation providing an increased bioavailability of hydrophobic drugs
Alza 1556000*

Methods of administering and enhancing absorption of pharmaceutical agents
Generex Pharmaceuticals 1556003*

Substituted tetracycline compounds for the treatment of malaria
Paratek Pharmaceuticals 1556007*

Uses of bases for the manufacture of a medicament in the treatment of inflammatory dermatosis
Dermatrands 1556008*

Pharmaceutical formulations targeting specific regions of the gastrointestinal tract
SuperGen 1556010*

Therapeutic compsns
Polymerix 1556011*

Method for producing solid galenic formulations using a crosslinked non-thermoplastic carrier
Abbott 1556012*

Deferacirox dispersible tablets
Novartis 1556013*

Sustained release compsns containing alfuzosin
Ranbaxy Laboratories 1556014*

Multilayer dosage forms, which contain active substances and which comprise a neutral core, and an inner and outer coating consisting of methacrylate copolymers and methacrylate monomers
Roehm 1556016*

Sustained release porous microparticles for inhalation
Acusphere 1556018*

Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase inhibitors
Merz Pharma 1556019*

Use of CGRP antagonist compounds for treatment of psoriasis
Sveinsson, Birkir 1556020*

Pharmaceutical compsns comprising flavonoids and menthol
Immunopharm 1556021*

Aqueous 2,6-diisopropylphenol pharmaceuticals
Transform Pharmaceuticals 1556022*

Nutritional or therapeutic compsns
Crum, Albert 1556023*

Pulsatile release compsns of milnacipran
Collegium Pharmaceutical 1556024*

Compsns comprising vitamin K for treating or preventing age-related stiffening of arteries
Vitak 1556025*

Modified pharmaceutical formulations of modafinil
Cephalon 1556026*

Modified amino acid for the inhibition of platelet aggregation
Novartis 1556027*

Eicosapentaenoic acid (EP4) for treating anorexia nervosa (AN) and bulimia
Amarin Neurosciences 1556028*

Thiomolybdate analogues and uses thereof
Attenuon 1556029*

Taxane metabolites
Bristol-Myers Squibb 1556030*

Chromones and chromone derivatives and uses thereof
Jenken Bioscience 1556031*

Agent for preventing or treating neuropathy
Takeda Pharmaceutical 1556032*

Methods and compsns using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
Celgene Corp 1556033*

Indole derivatives as beta-2 agonists
Pfizer 1556034*

Novel aromatic compounds possessing antifungal or antibacterial activity
Genelabs Technologies 1556035*

Use of iminosugar derivatives to inhibit ion channel activity
The Chancellor, Masters and Scholars of the University of Oxford 1556036*

4-piperazinyl benzenesulphonyl indoles with 5-HT6 receptor affinity
F Hoffmann-La Roche 1556037*

Acetophenone potentiators of metabotropic glutamate receptors
Merck 1556038*

Process for the preparation of trinitrogen-containing heteroaryldiamine derivatives useful as pharmaceutical agents and methods of producing pharmaceutical agents
Bristol-Myers Squibb 1556039*

Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 and type 2
Sterix 1556040*

A new crystalline form of the sodium salt of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid
Zentiva 1556041*

Combinations of benzothiazoles and COX-2 inhibitors for the treatment of pain
Novartis 1556042*

Amorphous form of esomeprazole salts
Ranbaxy Laboratories 1556043*

Methods of using and compsns comprising immunomodulatory compounds for treatment, modification and management of pain
Celgene 1556044*

4-aminopiperidine derivatives, processes for their preparation and their use as medicaments
UCB 1556045*

Phenylpiperidines and phenyl pyrrolidenes as histamine H3 receptor modulators
Janssen Pharmaceutica 1556046*

PDG2 receptor antagonists for the treatment of inflammatory diseases
MIllennium Pharmaceuticals 1556047*

Effervescent formulations comprising apomorphine
Ardana Bioscience 1556048*

Piperidine-pyridazones and phthalazones as PDE4 inhibitors
Altana Pharma AG 1556049*

Pharmaceutical compsns of ganciclovir
Ranbaxy Laboratories 1556050*

Synergistic methods and compsns for treating cancer
Bristol-Myers Squibb 1556051*

Mitotic kinesin inhibitors
Merck 1556052*

Antagonising NK1 receptors inhibits consumption of substances of abuse
The Regents of the University of California 1556054*